从2025年到2050年预测COPD的全球经济和健康负担
Elroy Boers1, Angier Allen2, Meredith Barrett2
1ResMed Science Center, Halifax, NS, Canada.
Chest
|April 20, 2025
概括
预计到2050年,慢性阻塞性肺病 (COPD) 的全球经济负担将超过39万亿美元. 减少吸烟和空气污染等风险因素对于减轻这种严重的健康和经济影响至关重要.
科学领域:
- 肺部医学 肺部医学
- 卫生经济学 卫生经济学
- 流行病学 流行病学
背景情况:
- 之前的研究估计了慢性阻塞性肺病 (COPD) 的经济和健康负担.
- 现有的估计在很大程度上局限于当前数据或短期预测.
研究的目的:
- 预测COPD从2025年到2050年的区域和全球经济和健康负担的变化.
- 将COPD风险因素和人口扩张的趋势纳入未来负担预测.
主要方法:
- 一个开放的队列马尔科夫模型被开发来预测COPD的经济和健康负担到2050年.
- 根据年龄,性别和吸烟情况分析了COPD成本.
- 模拟了吸烟,空气污染 (家庭,PM2.5,臭氧) 和COPD严重性的全球趋势.
主要成果:
- 预计到2050年,COPD的累计全球直接成本将达到24.35万亿美元.
- 到2050年,累计的全球间接成本估计为15.43万亿美元.
- 据估计,在2025年至2050年期间,COPD恶化预计将达到156亿次.
结论:
- 针对吸烟和空气污染等风险因素的预防策略至关重要.
- 医疗保健政策改革是必要的,以改善治疗机会和患者的治疗结果.
- 创新方法对于提高COPD的管理和结果至关重要.
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
COPD: Pathogenesis and Clinical Features
223
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
223
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


